Myelodysplastic syndromes in Latin America: State of the art

Autores
Crisp, Renée; Grillé, Sofía; Belli, Carolina Bárbara; Diaz, Lilian; Undurraga, Soledad; Navarro, Juan; Vidal, Gabriela; Gusmao, Breno; Reyes, Jheremy; Huaman Garaicoa, Fuad; Magalhaes, Silvia; Barroso, Fernando; Ovilla, Roberto; Flores, Gabriela; Choque, Juan; Distéfano, Marcos; Salinas Viedma, Victor; Iastrebner, Marcelo
Año de publicación
2018
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Latin America is a group of countries that covers an area of approximately 19 197 000 km2. In 2016, itspopulation was estimated at more than 639 million. The prevalent languages are Spanish andPortuguese.Myelodysplastic syndromes (MDSs) are a heterogeneous group of myeloid neoplasms characterized byabnormal differentiation and maturation of myeloid cells, bone marrow failure, and genetic instability withenhanced risk of transforming to acute myeloid leukemia.The incidence rates for MDS in Europe and the United States range from 3 to 5 per 100 000 personyearsand increase markedly with age to 20 per 100 000 person-years for those older than age 70 years.Despite the absence of epidemiologic data, Latin America also has an aging population, as with otherdeveloped countries, and an increasing rate of secondary MDS from previous toxic exposure not only asa consequence of treating other malignancies but also as a result of environmental or occupationalfactors. Diagnosis and treatment remain difficult because of the high number of economic andtechnological disparities within and among Latin American countries.
Fil: Crisp, Renée. Hospital Nacional "a Posadas"; Argentina
Fil: Grillé, Sofía. Hospital de Clínicas; Uruguay
Fil: Belli, Carolina Bárbara. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina
Fil: Diaz, Lilian. Hospital de Clínicas; Uruguay
Fil: Undurraga, Soledad. Hospital El Salvador; Chile
Fil: Navarro, Juan. Hospital Nacional Edgardo Rebagliati Martins; Perú
Fil: Vidal, Gabriela. Hospital Nacional Edgardo Rebagliati Martins; Perú
Fil: Gusmao, Breno. Hospital Israelita Albert Einstein; Brasil
Fil: Reyes, Jheremy. Clínica Los Nogales; Colombia
Fil: Huaman Garaicoa, Fuad. Instituto Oncológico Nacional Dr. J. Tanca Marengo; Ecuador
Fil: Magalhaes, Silvia. Universidade Federal Do Ceara; Brasil
Fil: Barroso, Fernando. Universidade Estadual do Ceará; Brasil
Fil: Ovilla, Roberto. Hospital Angeles Lomas; México
Fil: Flores, Gabriela. Gobierno de Ciudad de Buenos Aires. Hospital General de Agudos "Carlos G. Durand"; Argentina
Fil: Choque, Juan. Hospital de Especialidades Materno Infantil; Bolivia
Fil: Distéfano, Marcos. Hospital Domingo Luciani; Venezuela
Fil: Salinas Viedma, Victor. Instituto de Prevision Social; Paraguay
Fil: Iastrebner, Marcelo. Sanatorio Sagrado Corazón; Argentina
Materia
Myelodysplastic Syndromes
Latinamerica
GLAM
Grupo Latinoamericano de Mielodisplasia
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/95945
Acceder
id CONICETDig_21ca9085475453c5eab2cd34d8fde02d
oai_identifier_str oai:ri.conicet.gov.ar:11336/95945
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Myelodysplastic syndromes in Latin America: State of the artCrisp, RenéeGrillé, SofíaBelli, Carolina BárbaraDiaz, LilianUndurraga, SoledadNavarro, JuanVidal, GabrielaGusmao, BrenoReyes, JheremyHuaman Garaicoa, FuadMagalhaes, SilviaBarroso, FernandoOvilla, RobertoFlores, GabrielaChoque, JuanDistéfano, MarcosSalinas Viedma, VictorIastrebner, MarceloMyelodysplastic SyndromesLatinamericaGLAMGrupo Latinoamericano de Mielodisplasiahttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Latin America is a group of countries that covers an area of approximately 19 197 000 km2. In 2016, itspopulation was estimated at more than 639 million. The prevalent languages are Spanish andPortuguese.Myelodysplastic syndromes (MDSs) are a heterogeneous group of myeloid neoplasms characterized byabnormal differentiation and maturation of myeloid cells, bone marrow failure, and genetic instability withenhanced risk of transforming to acute myeloid leukemia.The incidence rates for MDS in Europe and the United States range from 3 to 5 per 100 000 personyearsand increase markedly with age to 20 per 100 000 person-years for those older than age 70 years.Despite the absence of epidemiologic data, Latin America also has an aging population, as with otherdeveloped countries, and an increasing rate of secondary MDS from previous toxic exposure not only asa consequence of treating other malignancies but also as a result of environmental or occupationalfactors. Diagnosis and treatment remain difficult because of the high number of economic andtechnological disparities within and among Latin American countries.Fil: Crisp, Renée. Hospital Nacional "a Posadas"; ArgentinaFil: Grillé, Sofía. Hospital de Clínicas; UruguayFil: Belli, Carolina Bárbara. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; ArgentinaFil: Diaz, Lilian. Hospital de Clínicas; UruguayFil: Undurraga, Soledad. Hospital El Salvador; ChileFil: Navarro, Juan. Hospital Nacional Edgardo Rebagliati Martins; PerúFil: Vidal, Gabriela. Hospital Nacional Edgardo Rebagliati Martins; PerúFil: Gusmao, Breno. Hospital Israelita Albert Einstein; BrasilFil: Reyes, Jheremy. Clínica Los Nogales; ColombiaFil: Huaman Garaicoa, Fuad. Instituto Oncológico Nacional Dr. J. Tanca Marengo; EcuadorFil: Magalhaes, Silvia. Universidade Federal Do Ceara; BrasilFil: Barroso, Fernando. Universidade Estadual do Ceará; BrasilFil: Ovilla, Roberto. Hospital Angeles Lomas; MéxicoFil: Flores, Gabriela. Gobierno de Ciudad de Buenos Aires. Hospital General de Agudos "Carlos G. Durand"; ArgentinaFil: Choque, Juan. Hospital de Especialidades Materno Infantil; BoliviaFil: Distéfano, Marcos. Hospital Domingo Luciani; VenezuelaFil: Salinas Viedma, Victor. Instituto de Prevision Social; ParaguayFil: Iastrebner, Marcelo. Sanatorio Sagrado Corazón; ArgentinaAmerican Society of Hematology2018-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/95945Crisp, Renée; Grillé, Sofía; Belli, Carolina Bárbara; Diaz, Lilian; Undurraga, Soledad; et al.; Myelodysplastic syndromes in Latin America: State of the art; American Society of Hematology; Blood Advances; 2; 12-2018; 60-622473-95292473-9537CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1182/bloodadvances.2018GS110862info:eu-repo/semantics/altIdentifier/url/https://ashpublications.org/bloodadvances/article/2/Supplement_1/60/422707/Myelodysplastic-syndromes-in-Latin-America-stateinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:07:16Zoai:ri.conicet.gov.ar:11336/95945instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:07:16.661CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Myelodysplastic syndromes in Latin America: State of the art
title Myelodysplastic syndromes in Latin America: State of the art
spellingShingle Myelodysplastic syndromes in Latin America: State of the art
Crisp, Renée
Myelodysplastic Syndromes
Latinamerica
GLAM
Grupo Latinoamericano de Mielodisplasia
title_short Myelodysplastic syndromes in Latin America: State of the art
title_full Myelodysplastic syndromes in Latin America: State of the art
title_fullStr Myelodysplastic syndromes in Latin America: State of the art
title_full_unstemmed Myelodysplastic syndromes in Latin America: State of the art
title_sort Myelodysplastic syndromes in Latin America: State of the art
dc.creator.none.fl_str_mv Crisp, Renée
Grillé, Sofía
Belli, Carolina Bárbara
Diaz, Lilian
Undurraga, Soledad
Navarro, Juan
Vidal, Gabriela
Gusmao, Breno
Reyes, Jheremy
Huaman Garaicoa, Fuad
Magalhaes, Silvia
Barroso, Fernando
Ovilla, Roberto
Flores, Gabriela
Choque, Juan
Distéfano, Marcos
Salinas Viedma, Victor
Iastrebner, Marcelo
author Crisp, Renée
author_facet Crisp, Renée
Grillé, Sofía
Belli, Carolina Bárbara
Diaz, Lilian
Undurraga, Soledad
Navarro, Juan
Vidal, Gabriela
Gusmao, Breno
Reyes, Jheremy
Huaman Garaicoa, Fuad
Magalhaes, Silvia
Barroso, Fernando
Ovilla, Roberto
Flores, Gabriela
Choque, Juan
Distéfano, Marcos
Salinas Viedma, Victor
Iastrebner, Marcelo
author_role author
author2 Grillé, Sofía
Belli, Carolina Bárbara
Diaz, Lilian
Undurraga, Soledad
Navarro, Juan
Vidal, Gabriela
Gusmao, Breno
Reyes, Jheremy
Huaman Garaicoa, Fuad
Magalhaes, Silvia
Barroso, Fernando
Ovilla, Roberto
Flores, Gabriela
Choque, Juan
Distéfano, Marcos
Salinas Viedma, Victor
Iastrebner, Marcelo
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Myelodysplastic Syndromes
Latinamerica
GLAM
Grupo Latinoamericano de Mielodisplasia
topic Myelodysplastic Syndromes
Latinamerica
GLAM
Grupo Latinoamericano de Mielodisplasia
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Latin America is a group of countries that covers an area of approximately 19 197 000 km2. In 2016, itspopulation was estimated at more than 639 million. The prevalent languages are Spanish andPortuguese.Myelodysplastic syndromes (MDSs) are a heterogeneous group of myeloid neoplasms characterized byabnormal differentiation and maturation of myeloid cells, bone marrow failure, and genetic instability withenhanced risk of transforming to acute myeloid leukemia.The incidence rates for MDS in Europe and the United States range from 3 to 5 per 100 000 personyearsand increase markedly with age to 20 per 100 000 person-years for those older than age 70 years.Despite the absence of epidemiologic data, Latin America also has an aging population, as with otherdeveloped countries, and an increasing rate of secondary MDS from previous toxic exposure not only asa consequence of treating other malignancies but also as a result of environmental or occupationalfactors. Diagnosis and treatment remain difficult because of the high number of economic andtechnological disparities within and among Latin American countries.
Fil: Crisp, Renée. Hospital Nacional "a Posadas"; Argentina
Fil: Grillé, Sofía. Hospital de Clínicas; Uruguay
Fil: Belli, Carolina Bárbara. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina
Fil: Diaz, Lilian. Hospital de Clínicas; Uruguay
Fil: Undurraga, Soledad. Hospital El Salvador; Chile
Fil: Navarro, Juan. Hospital Nacional Edgardo Rebagliati Martins; Perú
Fil: Vidal, Gabriela. Hospital Nacional Edgardo Rebagliati Martins; Perú
Fil: Gusmao, Breno. Hospital Israelita Albert Einstein; Brasil
Fil: Reyes, Jheremy. Clínica Los Nogales; Colombia
Fil: Huaman Garaicoa, Fuad. Instituto Oncológico Nacional Dr. J. Tanca Marengo; Ecuador
Fil: Magalhaes, Silvia. Universidade Federal Do Ceara; Brasil
Fil: Barroso, Fernando. Universidade Estadual do Ceará; Brasil
Fil: Ovilla, Roberto. Hospital Angeles Lomas; México
Fil: Flores, Gabriela. Gobierno de Ciudad de Buenos Aires. Hospital General de Agudos "Carlos G. Durand"; Argentina
Fil: Choque, Juan. Hospital de Especialidades Materno Infantil; Bolivia
Fil: Distéfano, Marcos. Hospital Domingo Luciani; Venezuela
Fil: Salinas Viedma, Victor. Instituto de Prevision Social; Paraguay
Fil: Iastrebner, Marcelo. Sanatorio Sagrado Corazón; Argentina
description Latin America is a group of countries that covers an area of approximately 19 197 000 km2. In 2016, itspopulation was estimated at more than 639 million. The prevalent languages are Spanish andPortuguese.Myelodysplastic syndromes (MDSs) are a heterogeneous group of myeloid neoplasms characterized byabnormal differentiation and maturation of myeloid cells, bone marrow failure, and genetic instability withenhanced risk of transforming to acute myeloid leukemia.The incidence rates for MDS in Europe and the United States range from 3 to 5 per 100 000 personyearsand increase markedly with age to 20 per 100 000 person-years for those older than age 70 years.Despite the absence of epidemiologic data, Latin America also has an aging population, as with otherdeveloped countries, and an increasing rate of secondary MDS from previous toxic exposure not only asa consequence of treating other malignancies but also as a result of environmental or occupationalfactors. Diagnosis and treatment remain difficult because of the high number of economic andtechnological disparities within and among Latin American countries.
publishDate 2018
dc.date.none.fl_str_mv 2018-12
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/95945
Crisp, Renée; Grillé, Sofía; Belli, Carolina Bárbara; Diaz, Lilian; Undurraga, Soledad; et al.; Myelodysplastic syndromes in Latin America: State of the art; American Society of Hematology; Blood Advances; 2; 12-2018; 60-62
2473-9529
2473-9537
CONICET Digital
CONICET
url http://hdl.handle.net/11336/95945
identifier_str_mv Crisp, Renée; Grillé, Sofía; Belli, Carolina Bárbara; Diaz, Lilian; Undurraga, Soledad; et al.; Myelodysplastic syndromes in Latin America: State of the art; American Society of Hematology; Blood Advances; 2; 12-2018; 60-62
2473-9529
2473-9537
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1182/bloodadvances.2018GS110862
info:eu-repo/semantics/altIdentifier/url/https://ashpublications.org/bloodadvances/article/2/Supplement_1/60/422707/Myelodysplastic-syndromes-in-Latin-America-state
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv American Society of Hematology
publisher.none.fl_str_mv American Society of Hematology
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842269996729761792
score 13.13397

Publicaciones similares